Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 4, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

[Primary myxoid mediastinal liposarcoma].

J-M Perotin1, G Deslee, D Perdu

  • 1Service des Maladies Respiratoires, IFR 53, Hôpital Maison-Blanche, CHU de Reims, 45 rue Cognacq-Jay, 51100 Reims, France. jeanne-marie.perotin@etudiant.univ-reims.fr

Revue Des Maladies Respiratoires
|February 1, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same author

[Resistance to immunotherapy in non-small cell lung cancer: State of the art].

Revue des maladies respiratoires·2026
Same author

[Social care for adult cystic fibrosis patients in clinical practice].

Revue des maladies respiratoires·2025
Same author

Lung toxicity related to trimethoprim/sulfamethoxazole: pharmacovigilance data review.

The Journal of antimicrobial chemotherapy·2025
Same author

[Take-home messages from the 2nd COPD 2023 Biennial of the French Society of Respiratory Diseases. Placing the patient at the center of the care pathway].

Revue des maladies respiratoires·2024
Same author

[Second COPD biennial of the French Society of Respiratory Diseases: Major changes].

Revue des maladies respiratoires·2024
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

This case report details a rare mediastinal liposarcoma (LPS) successfully treated with chemotherapy, surgery, and radiation. Early diagnosis and multimodal therapy led to no recurrence 18 months post-treatment.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Radiotherapy

Background:

  • Mediastinal liposarcomas (LPS) are uncommon malignant neoplasms.
  • These bulky tumors present a diagnostic and therapeutic challenge due to their rarity and location.

Observation:

  • A 22-year-old woman presented with cough, exertional dyspnea, and asthenia.
  • Thoracic MRI revealed a large, right-sided mediastinal mass.

Findings:

  • The patient underwent neoadjuvant chemotherapy followed by complete surgical resection.
  • Adjuvant thoracic irradiation was administered post-operatively.
  • No signs of recurrence were observed 18 months after diagnosis.

Implications:

  • Complete tumor resection is crucial for favorable prognosis in mediastinal liposarcoma.

Related Experiment Videos

Last Updated: Jun 4, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

  • The histological subtype influences tumor progression and patient outcomes.
  • Established adjuvant therapies for mediastinal LPS are lacking, highlighting the need for further research.